Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29DA008899-02
Application #
2121725
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1995-07-01
Project End
2000-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Duke University
Department
Psychiatry
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
King, George R; Hillburn, Craig; Pinto, Gail et al. (2004) The effects of continuous cocaine dose, treatment, and withdrawal duration on the induction of behavioral tolerance and dopamine autoreceptor function. Pharmacol Biochem Behav 78:293-300
Matell, Matthew S; King, George R; Meck, Warren H (2004) Differential modulation of clock speed by the administration of intermittent versus continuous cocaine. Behav Neurosci 118:150-6
King, George R; Pinto, Gail; Konen, Jennifer et al. (2002) The effects of continuous cocaine duration on the induction of behavioral tolerance and dopamine autoreceptor function. Eur J Pharmacol 446:111-8
King, George R; Pinto, Gail; Konen, Jennifer et al. (2002) The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine. Eur J Pharmacol 449:253-9
King, G R; Xiong, Z; Douglass, S et al. (2000) Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J Pharmacol 394:97-101
King, G R; Xiong, Z; Ellinwood Jr, E H (1999) Withdrawal from continuous cocaine administration: time dependent changes in accumbens 5-HT3 receptor function and behavioral tolerance. Psychopharmacology (Berl) 142:352-9
King, G R; Xiong, Z; Douglas, S et al. (1999) The effects of continuous cocaine dose on the induction of behavioral tolerance and dopamine autoreceptor function. Eur J Pharmacol 376:207-15
King, G R; Xiong, Z; Ellinwood Jr, E H (1998) Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine. Psychopharmacology (Berl) 135:263-9